Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103827 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL100741 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101628 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101603 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL102969 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL23577086 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL101803 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL201904 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL200853 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 | |
| SCHEMBL102911 | 1.00 | LMNA (0.52) | LMNAALDH1A1TDP1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-106892915-B | Organic compound, organic electroluminescence device and its application | 南京高光半导体材料有限公司 | 2019-02-22 | — | — | CN | disclosed |
| CN-104513510-B | Colored curable resin composition | 东友精细化工有限公司 | 2018-07-06 | — | — | CN | disclosed |
| CN-104125839-B | Absorber and the absorbent commodity for having used the absorber | 株式会社利卫多公司 | 2017-09-01 | — | — | CN | disclosed |
| CN-106892915-A | Organic compound, organic electroluminescence device and its application | 南京高光半导体材料有限公司 | 2017-06-27 | — | — | CN | disclosed |
| CN-103068786-B | Cosmetic preparation | COGNIS IP MANAGEMENT GMBH (DE) | 2016-01-20 | — | — | CN | disclosed |
| CN-104513510-A | Coloring and solidifying resin composition | SUMITOMO CHEMICAL CO | 2015-04-15 | — | — | CN | disclosed |
| US-8940943-B2 | Cosmetic preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-27 | — | — | US | disclosed |
| CN-104125839-A | Absorber and absorbent article using the same | LIVEDO CORP | 2014-10-29 | — | — | CN | disclosed |
| EP-2601166-A1 | COSMETIC PREPARATIONS | Cognis IP Management GmbH (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20130131188-A1 | Cosmetic Preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| CN-103068786-A | Cosmetic preparation | COGNIS IP MAN GMBH | 2013-04-24 | — | — | CN | disclosed |
| EP-2426101-A1 | Cosmetic preparations | Cognis IP Management GmbH (DE) | 2012-03-07 | — | — | EP | disclosed |
| WO-2012016642-A1 | COSMETIC PREPARATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-4640913-A | Phosphocholine derivatives having antihypertensive action | AMERICAN CYANAMID COMPANY (US) | 1987-02-03 | — | — | US | disclosed |
| US-4296129-A | ANTIAASTHMATIC INHIBITOR OF SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS | PFIZER, INC. (US) | 1981-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131188-A1 | Cosmetic Preparations | CYP1B1, CBR1, ACOX3 | LMNA 1943/4885ALDH1A1 100/4885TDP1 2710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.